Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy

Contraception

Volumn 54, Issue 2, 1996, Pages 59-69

  Fotherby, K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

bioavailability; estrogens; gestogens; hormone replacement therapy; oral contraceptives; prodrug

Indexed keywords

CONJUGATED ESTROGEN; DESOGESTREL; DIHYDROEQUILIN; EQUILENIN; EQUILIN; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTRONE; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; GESTODENE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PRODRUG; PROGESTERONE; SEX HORMONE;

DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FORMULATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; NONHUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0030222222     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00136-9     Document Type: Review

References (52)

1. 1. Fotherby K. A critical evaluation of the pharmacokinetics of contraceptive steroids. In: Snow R, Hall P, eds. Steroid Contraceptives and Women's Response. New York: Plenum Press, 1994:125-32.
2. 2. Roberts RJ, Leff RD. Influence of lipid substances on drug bioavailability. Clin Pharmacol Ther 1989;45:299-304.
3. 3. Englund DE, Johansson EDB. Oral versus vaginal absorption in oestradiol. Uppsala J Med Sci 1981;86:297-307.
4. 4. Schindler AE, Bolt HM, Zimmer M, Hochlenert G, Goser R. Comparative pharmacokinetics of oestrogens after oral administration. Arzneim-Forsch (Drug Res) 1982;32:787-91.
5. 5. Kuhnz W, Gansau C, Mahler M. Pharmacokinetics of estradiol after intravenous and oral administration. Arzneim-Forsch (Drug Res) 1993;43:966-73.
6. 6. Anderson ABM, Sklovsky E, Sayers L, Steele PA, Turnbull AC. Comparison of serum oestrogen concentrations in postmenopausal women taking oestrone sulphate and oestradiol. Br Med J 1978;1:140-2.
7. 7. Aedo AR, Sunden M, Landgren BM, Diczfalusy E. Effect of orally administered oestrogens on oestrogen profiles. Maturitas 1989;11:159-68.
8. 8. Aedo AR, Landgren BM, Diczfalusy E. Pharmacokinetics of orally administered oestrone sulphate and oestradiol valerate. Maturitas 1990;12:333-43.
9. 9. Englund DE, Johansson EDB. Plasma levels of oestrogens after oral and vaginal administration of Premarin. Br J Obstet Gynaecol 1978;85:957-64.
10. 10. Fotherby K. Pharmacokinetics of ethynyloestradiol in humans. Meth Find Expth Clin Pharmacol 1982;4:133-41.
11. 11. Goebelsmann U, Hoffman D, Chiang S, Woutersz T. Relative bioavailability of levonorgestrel and ethinylestradiol. Contraception 1986;34:341-51.
12. 12. Stanczyk FZ, Lobo RA, Chiang ST, Woutersz T. Pharmacokinetic comparison of contraceptive formulations containing levonorgestrel and ethinylestradiol. Contraception 1990;41:39-53.
13. 13. Fotherby K, Akpoviroro J, Adel-Ralman HA, et al. Pharmacokinetics of ethynyloestradiol in women from different populations. Contraception 1981;23:489-96.
14. 14. Borth R. Generic names for steroid hormones and related substances. Contraception 1975;2:373-6.
15. 15. Fotherby K. Potency and pharmacokinetics of gestogens. Contraception 1990;41:533-50.
16. 16. Kinel FA, Ciaccio LA, Benagiano G. Increasing oral bioavailability of progesterone by formulation. J Steroid Biochem 1978;9:83-4.
17. 17. Whitehead MJ, Townsend PT, Gill DK, Collins WP, Campbell, S. Absorption and metabolism of oral progesterone. Br Med J 1980;1:825.
18. 18. Morville R, Dray F, Reynier J and Barrat J. Biodisponsibilité de la progesterone administree par voie. J Gynaecol Obstet Biol Reprod (Paris) 1982;II:355-63.
19. 19. Maxson WS, Hargrove JT. Bioavailability of oral micronized progesterone. Fertil Steril 1985;44:622-6.
20. 20. Hargrove JT, Maxson WS, Wentz AC. Absorption of oral progesterone is influenced by vehicle and particular size. Am J Obstet Gynecol 1989;161:948-51.
21. 21. Simon JA, Robinson DE, Andrews MC, et al. The absorption of oral micronized progesterone: the effect of food dose proportionality, and comparison with intramuscular progesterone. Fertil Steril 1993;60:26-33.
22. 22. Fotherby K, Shrimanker K, Abdel-Rahman HA, et al. Rate of metabolism of norethisterone in women from different populations. Contraception 1979;19:39-45.
23. 23. Shi YE, He CH, Gu J, Fotherby K. Pharmacokinetics of norethisterone in humans. Contraception 1987;35:465-75.
24. 24. Brody SA, Turkes A, Goldzieher JW. Pharmacokinetics of three norethindrone-mestranol combinations. Contraception 1989;40:269-84.
25. 25. Back DJ, Breckenridge AM, Crawford FE, et al. Kinetics of norethisterone in women. Clin Pharm Ther 1978;24: 448-53.
26. 26. Saperstein S, Edgren RA, Jung D, et al. Pharmacokinetics of norethindrone: effect of particle size. Contraception 1989;40:731-40.
27. 27. Fotherby K. Levonorgestrel; clinical pharmacokinetics. Clin Pharmacokinet 1995;28:203-15.
28. 28. Hassenack HG, Bosch AMG, Kaar K. Serum levels of 3-ketodesogestrel after oral administration. Contraception 1986;33:591-6.
29. 29. Back DJ, Grimmer SFM, Sheppey N, Orme ML. Plasma concentrations of 3-ketodesogestrel. Contraception 1987;35:619-25.
30. 30. Berginck W, Assendorp R, Kloosterboer I, et al. Pharmacokinetics of orally administered desogestrel. Am J Obstet Gynecol 1990;163:2132-7.
31. 31. Mazaheri A, Fotherby K, Chapman JR. Metabolism of lynestrenol to norethisterone by liver homogenate. J Endocrinol 1970;4:251-2.
32. 32. Viinikka L. Metabolism of desogestrel by human liver. J Steroid Biochem 1979;10:353-9.
33. 33. Madden S. Back DJ, Orme ML. Metabolism of desogestrel by human liver. J Steroid Biochem 1990;35: 281-8.
34. 34. Fotherby K. Pharmacokinetics and metabolism of progestins in humans. In: Goldzieher JW, Fotherby K, eds Pharmacology of the Contraceptive Steroids. New York: Raven Press, 1994:99-126.
35. 35. Kuhnz W, Blode H, Mahler M. Systemic availability of levonorgestrel after oral administration of norgestimate. Contraception 1994;49:255-63.
36. 36. Helmreich ML, Huseby RA. Factors influencing the absorption of medroxyprogesterone acetate. Steroids 1965;Suppl II:79-95.
37. 37. Smith DL, Pulliam AL, Forist AA. Comparative absorption of micronized and nonmicronized MPA in man. J Pharm Sci 1966;55:398-403.
38. 38. Johansson EDB, Johansson PB, Rasmussen SN. MPA pharmacokinetics after oral administration. Acta Pharmacol Toxicol 1986;58:311-7.
39. 39. Pannuti F, Camaggi CM, Strocchi E, et al. MPA relative bioavailability after high dose administration. Cancer Treat Rep 1984;66:2043-9.
40. 40. Fotherby K. Pharmacokinetics of gestogens. Am J Obstet Gynecol 1990;163:323-8.
41. 41. Fotherby K. Intrasubject variability in the pharmacokinetics of ethynyloestradiol. J Steroid Biochem 1991;38: 733-6.
42. 42. Fotherby K. Interactions with oral contraceptives. Am J Obstet Gynecol 1990;163:2153-9.
43. 43. Fotherby K, Caldwell ADS. New progestogens in oral contraception. Contraception 1994;49:31-2.
44. 44. Back DJ, Bates M, Breckenridge AM, et al. Pharmacokinetics of levonorgestrel and ethynyloestradiol. Contraception 1981;23:229-39.
45. 45. Orme M, Back DJ, Ward S, Green, S. Pharmacokinetics of ethynyloestradiol in the presence of gestodene and desogestrel. Contraception 1991;43:305-16.
46. 46. Back DJ, Breckenridge AM, Crawford FE, et al. Pharmacokinetics of ethynyloestradiol. Contraception 1979; 20:263-73.
47. 47. Grimmer SF, Back DJ, Orme M, et al. Bioavailability of ethynyloestradiol and levonorgestrel in women with an ileostomy. Contraception 1986;33:51-9.
48. 48. Back DJ, Grimmer SF, Rogers S, et al. Comparative pharmacokinetics of levonorgestrel and ethynyloestradiol. Contraception 1987;36:471-9.
49. 49. Timmer CJ, Apter D, Voortman G. Pharmacokinetics of 3-ketodesogestrel and ethynyloestradiol. Contraception 1990;42:629-41.
50. 50. Humpel M, Nieuweboer B, Wendt H, Speck U. Pharmacokinetics of ethynyloestradiol. Contraception 1979; 19:421-31.
51. 51. Humpel M, Wendt H, Pommerenke C, et al. Pharmacokinetics of levonorgestrel and a possible first pass effect. Contraception 1978;17:207-19.
52. 52. Tauber U, Tack JW, Matthes H. Single dose pharmacokinetics of gestodene. Contraception 1989;40:461-79.